Heterocyclic derivatives for treating TRPM3-mediated disorders

JP2026097968APending Publication Date: 2026-06-16KATHOLIEKE UNIV LEUVEN
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
KATHOLIEKE UNIV LEUVEN
Filing Date
2026-03-06
Publication Date
2026-06-16

Smart Images

  • Figure 2026097968000001
    Figure 2026097968000001
  • Figure 2026097968000002
    Figure 2026097968000002
  • Figure 2026097968000003
    Figure 2026097968000003
Patent Text Reader

Abstract

The present invention provides compounds useful for the prevention or treatment of TRPM3-mediated disorders, more specifically, disorders selected from pain and inflammatory hypersensitivity. [Solution] A compound represented by formula (I), or its stereoisomers, pharmaceutically acceptable salts, solvates, and / or polymorphs (wherein V is a saturated or unsaturated 3-14 member heterocycloalkyl or 5-14 member heteroaryl). JPEG2026097968000321.jpg64151
Need to check novelty before this filing date? Find Prior Art